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The subunit composition of N-methyl D-aspartate
receptors (NMDARs) is tightly regulated during
cortical development. NMDARs are initially domi-
nated by GluN2B (NR2B), whereas GluN2A (NR2A)
incorporation increases after birth. The function of
GluN2B-containing NMDARs during development,
however, is incompletely understood. We generated
a mouse in which we genetically replaced GluN2B
with GluN2A (2B/2A). Although this manipulation
restored NMDAR-mediated currents at glutamater-
gic synapses, it did not rescue GluN2B loss of
function. Protein translation-dependent homeostatic
synaptic plasticity is occluded in the absence of
GluN2B, and AMPA receptor contribution is enriched
at excitatory cortical synapses. Our experiments
indicate that specificity of GluN2B-mediated sig-
naling is due to its unique interaction with the protein
effector alpha calcium-calmodulin kinase II and the
regulation of the mTOR pathway. Homozygous
2B/2A mice exhibited high rates of lethality,
suppressed feeding, and depressed social explor-
atory behavior. These experiments indicate that
GluN2B-containing NMDARs activate unique cellular
processes that cannot be rescued by replacement
with GluN2A.
INTRODUCTION
Glutamatergic synapses provide themajority of excitatory neuro-
transmission in the brain, and the ionotropic receptors respon-
sible for rapid information transfer at these contacts areN-methyl
D-aspartate receptors (NMDARs) and a-amino-3-hydroxy-
5-methyl-4-isoxazole propionic acid receptors (AMPARs).
NMDAR activation results in calcium-ion influx, which links
synapse activation to intracellular signaling cascades which
control synaptic strength, neuronal excitability, and neuronalsurvival. NMDARs are heteromultimeric protein complexes con-
taining two GluN1 subunits (a single gene) and two GluN2 (NR2)
subunits, which are encoded by four genes in mammals
(GluN2A-D; also known asNR2A-D) (Meguro et al., 1992;Monyer
et al., 1992). Contribution of GluN2 subunits to the NMDAR
complex is precisely regulated during development, with early
postnatal receptors containing exclusively GluN2B subunits,
whereas increased incorporation of GluN2A subunits occurs
during a postnatal period of synapse maturation and cortical
circuit refinement (Monyer et al., 1994; Sheng et al., 1994).
Homozygous GluN2B genetic knockout (KO) animals die on
postnatal day 0 (P0) (Kutsuwada et al., 1996). By contrast,
GluN2A knockout animals are viable and fertile (Sakimura
et al., 1995). Due in part to the lethality of the GluN2B knockout
mutation, the role of this receptor subtype during development
remains unclear. In addition, the relative role of GluN2B- versus
GluN2A-containing NMDARs in synapse function has become
a highly debated issue, with potentially distinct roles ascribed
to these receptors in regimes of synaptic plasticity and meta-
plasticity (Yashiro and Philpot, 2008). Assigning unique func-
tional roles to GluN2B-containing NMDARs during development
is complicated by the fact that their exclusive expression
means that specific loss of GluN2B also results in total loss of
NMDAR signaling during this period. This poses a problem
for interpretation of data from GluN2B loss-of-function experi-
ments during postnatal development: which aspects of the
loss-of-function phenotype are due to loss of GluN2B signaling
specifically, and which are due to loss of NMDAR signaling
generally? To answer this question and improve our knowledge
of the distinct roles that GluN2B-containing NMDARs play in
regulating synapse function, we genetically replaced GluN2B
with GluN2A in mice (2B/2A). In these 2B/2A allelic ‘‘replace-
ment’’ animals, functional NMDAR current is recovered during
postnatal development, but the current is now mediated by
GluN2A-containing receptors in the absence of GluN2B.
We show here that premature expression of GluN2A is unable
to rescueGluN2B loss of function, demonstrating that this period
of GluN2B predominance is critical. Homozygous 2B/2A
animals suffer high rates of lethality, a dramatically suppressed
suckling reflex, and retarded body growth. This phenotype was
observed despite the fact that NMDAR-mediated currentsNeuron 72, 789–805, December 8, 2011 ª2011 Elsevier Inc. 789
Figure 1. Construction and Expression of the GluN2B-to-GluN2A Replacement Allele
(A) The genetic strategy replaced the first coding exon of GluN2B (top) with a full-length cDNA encoding the GluN2A subunit (middle). The targeting construct
(tConstruct) lacked the translation start codon of GluN2B and included a pgk-Neomycin resistance cassette used for in vitro selection. The resulting 2B/2A allele
(bottom) replaced the GluN2B gene with GluN2A.
(B) Genotyping data showing the presence (WT and HET) or absence (homozygous 2B/2A) of the GluN2B exon and replacement by GluN2A cDNA.
Approximate positions of PCR primers and product sizes are shown in (A).
(C and D) Western blot analysis of protein lysates from in vitro cultured neurons revealed the absence of GluN2B protein and premature expression of GluN2A in
homozygous 2B/2A neurons.
(E) RT-PCR results confirmed lack of GluN2B exon 4 transcript (2B) in mRNA samples from P17 2B/2A homozygous animals and replacement by GluN2A
mRNA. Endogenous GluN2A mRNA (m2A) could be distinguished from exogenous rat cDNA message (r2A).
(F) Western blot analysis of cortical lysates from P27 mice confirmed the genetic strategy in replacing GluN2B with GluN2A protein in vivo.
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synapses. Our experiments show that GluN2B-mediated
signaling is specifically required for proper AMPAR regulation
at developing cortical synapses, and loss of GluN2B occludes
protein translation-dependent homeostatic synaptic plasticity
in these neurons. Furthermore, we show that this is likely due
to the unique association between GluN2B and alpha calcium-
calmodulin kinase II (CaMKII) and involves regulation of the
mammalian/mechanistic target of rapamycin (mTOR) pathway.
The behavioral phenotype of homozygous 2B/2A mice
includes reduced social exploration in spite of exhibiting
hyperlocomotion. In summary, our experiments reveal a critical
role for GluN2B-mediated NMDAR signaling in regulating
cortical synapse development and protein translation-depen-
dent homeostatic synaptic plasticity, as well as show that selec-
tive loss of GluN2B function during development results in
behaviors consistent with mouse models of schizophrenia.
RESULTS
Generation and Characterization of the 2B/2A Mouse
To test the role of GluN2B-containing NMDARs during develop-
ment, we generated aGluN2B-to-GluN2A ‘‘replacement’’ mouse
(2B/2A). The genetic strategy is shown in Figure 1A. The first
coding exon of GluN2B (exon 4) was disrupted and replaced
with cDNA encoding GluN2A as well as a neomycin resistance
selection cassette. Following targeted homologous recombina-
tion, selection of properly targeted embryonic stem cells, and
generation of confirmed founder animals, the neomycin cassette
was removed by crossing animals with a protamine-driven Cre-
recombinase mouse line (JAX: 003328). Double heterozygous
(HET) male mice, containing a copy of the protamine-CRE trans-
gene and a copy of the 2B/2A allele, were mated with C57/BL6
wild-type (WT) female mice. PCR-based genotyping differenti-
ated between 2B/2A and WT GluN2B alleles and confirmed
removal of the neomycin selection cassette (Figure 1B). Western
blot analysis of cortical neuronal lysates, both in vitro and in vivo,
showed that GluN2A protein is expressed prematurely in this
animal in lieu of GluN2B (Figures 1C, 1D, and 1F). Western blot
analysis during development confirmed the continued absence
of GluN2B and the premature expression of GluN2A in 2B/2A
cortical neurons (see Figure S1 available online). RT-PCR anal-
ysis of mRNA harvested from P17 homozygous 2B/2A animals
showed the absence of GluN2B transcript and replacement with
exogenous rat mRNA encoding GluN2A, in addition to the
endogenous mouse transcript (Figure 1E). Together, these
data show that the genetic strategy was successful and predict
that in homozygous 2B/2A animals, glutamatergic cortical
synapses contain only GluN2A-containing receptors within
a GluN2B null background.
Genetic deletion of GluN2B leads to perinatal lethality (Kutsu-
wada et al., 1996). 2B/2A mice also displayed a high rate of(G) Photograph of a homozygous 2B/2A mouse and a littermate control anim
stomachs compared with littermate WTs (arrow).
(H) 2B/2A animals showed a highly significant decrease in mean body mass at
(I) Consistent with their reduced milk intake, 2B/2A animals exhibited significant
at P0. In this and in all figures, error bars are SEM.perinatal lethality, indicating that premature expression of
GluN2A is not sufficient to fully rescue GluN2B loss of function.
Genotyping embryos harvested to prepare cortical cultures
showed that the transmission frequency of the 2B/2A allele
followed a predicted pattern with an approximately 1:2:1
(WT:HET:2A/2B) ratio from matings between heterozygous
2B/2A animals (19:41:21, in ten cultures). However, onlyz8%
of 2A/2B homozygous animals survived past P0: 6 out of 72
predicted animals (24 months following removal of the neo
cassette, data from 38 litters). Surviving homozygous 2B/2A
pups exhibited no differences in size at P0 but were significantly
stunted in mass when measured as juveniles (P12–P16) (Figures
1G and 1H). In homozygous 2B/2A pups at P0, we recorded
a decrease in the number of rhythmic mouth suckling move-
ments in response to stimulationwith a feeding needle (Figure 1I),
suggestive of a weakened ability to feed. This is consistent with
an observed lack ofmilk in their bellies at this age (Figure 1G) and
is similar to the GluN2B full knockout animals, which show
a complete absence of suckling behavior.
Recovery of Surface NMDARs in 2B/2A Neurons
These observations underscore the importance of NMDAR
signaling during development but also suggest a required and
specific role for GluN2B-containing NMDARs. To determine
whether or not GluN2A-containing receptors were properly ex-
pressed and trafficked to the neuronal membrane in 2B/2A
mice, we generated neuronal cultures from homozygous
embryos as well as WT embryos at E16–E17 and performed
immunofluorescence analysis of GluN1. GluN1 is the obligate
subunit of the NMDAR, and thus its expression in dendrites will
correlate positively with total receptor levels. We measured
similar levels of anti-GluN1 staining in 2B/2A dendrites
compared toWT controls by costaining with the dendritic marker
MAP2 (Figure 2A). To examine surface-localized protein, we
used a live-labeling protocol. This analysis showed that the
amount of membrane-associated GluN1 protein in 2B/2A
neurons was comparable to WT (Figure 2B). Because GluN1
subunits do not traffic to the neuronal surface in the absence
of GluN2 (Horak et al., 2008) this suggests that levels of surface
membrane receptors are similar between genotypes. We also
observed comparable levels of GluN1 staining intensity in
2B/2A neurons when we examined the signal that colocalized
with the excitatory synapse marker VGluT1, suggesting that
levels of synaptically localized receptors are also comparable
(Figures 2B and S2A).
To confirm the presence of functional NMDARs on these
neurons, we applied localized NMDA stimulation (100 mM
NMDA + 10 mM D-serine) while recording from voltage-clamped
neurons at a holding potential of +50mV (Figure 2C). This allowed
us to investigate surface receptor responses independent of
presynaptic release. Interestingly, stimulation durations required
to evoke similar current amplitudes were higher for 2B/2Aal at P16. Observation of 2A/2B animals at P0 revealed lack of milk in their
P12–P16.
ly depressed suckling behavior in response to stimulation with a feeding needle
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Figure 2. GluN2A-Containing NMDAR-Mediated Responses in 2B/2A Cortical Neurons
(A) Immunofluorescent labeling of dendritesmarked byMAP2 staining revealed similar levels of the obligatory NMDAR subunit GluN1 onWT and 2B/2A neurons
(scale bar represents 5 mm).
(B) Live labeling revealed similar levels of surface-localized GluN1, whereas colocalization with the presynapticmarker VGluT1 revealed a slight increase in GluN1
putatively localized to synaptic sites in 2B/2A dendrites.
(C) Local application of NMDA (100 mM) and D-Serine (10 mM) evoked outward currents in WT and 2B/2A neurons voltage clamped at +50mV. These currents
were sensitive to the NMDAR antagonist MK801.
(D) For similar stimulus duration, currents in 2B/2A neurons were slightly depressed in terms of their peak amplitude.
(E) These NMDAR-mediated currents showed similar rates of use-dependent block in response to MK801 application and no difference in COV values, which
increased predictably in both genotypes as the population of activated receptors decreased (cf. 0 min and 8 min of MK801 application).
(F) Consistent with a pure population of GluN2A-containing NMDARs, responses evoked in 2B/2A neurons were insensitive to the GluN2B selective antagonist
ifenprodil but significantly more sensitive to the zinc ion chelator TPEN.
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slightly lower than control neurons at similar stimulation dura-
tions (Figure 2D). Although this suggested a decrease in the792 Neuron 72, 789–805, December 8, 2011 ª2011 Elsevier Inc.number of functional surface receptors, it is also consistent
with the observation that GluN2A-containing NMDARs have
lower agonist sensitivity than GluN2B (Erreger et al., 2007). In
Neuron
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increased (1 mM), response amplitudes were not significantly
different (Figure S2B). To further estimate the number of func-
tional membrane receptors, we applied coefficient of variance
(COV) analysis to the NMDA-evoked responses. As predicted,
application of the use-dependent NMDAR antagonist MK801
caused an increase in COV over time (Figures 2C and 2E).
However, we observed no significant difference in COV values
between WT and 2B/2A neurons at either high or low levels
of receptor blockade (Figure 2E). Single-channel recordings in
expression systems have shown that heteromeric GluN1/
GluN2A NMDARs exhibit higher open probability than GluN1/
GluN2B NMDARs, which predict a faster rate of block by
MK801 (Erreger et al., 2005; Chen et al., 1999). However, our
observations are consistent with other results in neurons (Speed
and Dobrunz, 2009; Chavis and Westbrook, 2001) and suggest
that, unlike in expression systems, GluN2A-containing NMDARs
in cortical neurons may have similar open channel probabilities
compared to those containing GluN2B. The pharmacological
profile of NMDAR currents in 2B/2A neurons was consistent
with a pure GluN2A-containing population because they were
insensitive to the GluN2B antagonist ifenprodil (3 mM), whereas
WT responses were blocked to nearly 50% (Figure 2F).
GluN2A-containing NMDARs are also more sensitive to ambient
zinc ions, and we observed that 2B/2A responses exhibited
significantly more potentiation following application of the zinc-
ion chelator TPEN (0.5 mM) (Figure 2F). Together, these data indi-
cate that GluN2A protein is expressed and, along with GluN1, is
able to form functional receptors in the absence of GluN2B.
Moreover, they suggest the presence of similar numbers of
NMDARs on 2B/2A neurons, although peak amplitudes of
NMDA-evoked currents were depressed, potentially due to the
dominance of extrasynaptic receptors to responses evoked
under this stimulation method and/or to decreased agonist
sensitivity of GluN2A-containing NMDARs.
Recovery of Synaptic NMDARs in 2B/2A Neurons
Responses evoked by localized NMDA application in vitro are
the result of activation of both synaptic and extrasynaptic recep-
tors. We next carried out experiments in acute slices to confirm
the presence of synaptic NMDAR-mediated currents ex vivo.
GluN2A-containing NMDARs have been shown to traffic to
autaptic synapses in GluN2B null hippocampal cultures and in
cultured cortical slices following knockdown of GluN2B (Tovar
et al., 2000; Barria and Malinow, 2002). However, their ability
to traffic to GluN2B null synapses in vivo had not been tested.
We recorded whole-cell currents from layer II/III cortical neurons
in acute brain slices in response to presynaptic stimulation in
layer IV of 2B/2A animals (P12–P16) (Figure 3). Voltage clamp-
ing at depolarized potentials to remove the Mg2+ block of
NMDARs and electrically stimulating afferent axons allowed us
to record APV-sensitive currents in 2B/2A cortex (Figures 3A
and 3B). The peak amplitude of the synaptic NMDAR-mediated
current at +50mV was not significantly different in 2B/2A mice
compared to controls (Figure 3B). Consistent with a pure
population of GluN2A-containing receptors, these recordings
revealed a lack of sensitivity to the GluN2B selective antagonist
ifenprodil (Figure 3C) and to NMDAR-mediated currents thatexhibited significantly faster decay times (decreased tau) (Fig-
ure 3D) (Vicini et al., 1998). Faster decay resulted in a slight,
but statistically significant, decrease in integrated current
measured at +50mV over the initial 200 ms of the evoked
response, but not over the initial 100 ms of the response (Fig-
ure 3D). These data show that our genetic strategy was success-
ful in removing GluN2B and driving precocious expression and
synaptic incorporation of GluN2A-mediated NMDAR-receptors
while recovering a significant amount of synaptic NMDAR-medi-
ated current at cortical synapses in vivo.
GluN2B-Mediated Signaling Is Required for Proper
AMPAR Regulation and Homeostatic Synaptic Plasticity
in Developing Cortical Networks
GluN2B andGluN2A interact with, and activate, distinct signaling
cascades at excitatory synapses in order to control the compo-
sition and strength of synaptic contacts. The dominant way by
which NMDARs regulate synaptic strength is through bidirec-
tional trafficking of AMPARs. In light of this, we examined
AMPAR-mediated currents in 2B/2A mice. For these experi-
ments, cortical neuron cultures were prepared from both
homozygous GluN2B knockout and 2B/2A embryos, as well
as from WT littermate embryos. We isolated AMPAR-mediated
miniature excitatory postsynaptic currents (mEPSCs) between
11 and 15 days in vitro (DIV) using 0.5 mM tetrodotoxin (TTX) +
50 mM picrotoxin. In both GluN2B null and 2B/2A cultures,
we observed a significant increase in mean mEPSC amplitudes
(Figure 4A), showing that individual cortical synapses had
enriched AMPAR contribution in the absence of GluN2B. This
is consistent with published data showing that NMDAR
signaling, under basal levels of activity, can act to suppress
incorporation of AMPARs at glutamatergic synapses (Hall
et al., 2007; Ultanir et al., 2007; Hall and Ghosh, 2008; Adesnik
et al., 2008; Engblom et al., 2008).
The inability of GluN2A to rescue mEPSC amplitudes in 2B/
2A neurons predicts a unique role for GluN2B-containing
NMDARs in regulating AMPAR current development in cortical
neurons. The increase in mEPSC amplitudes, both in GluN2B
null and 2B/2A neurons, was multiplicative (slope: GluN2B
null = 1.85, R = 0.984; 2B/2A = 1.64, R = 0.99) (Figure 4A).
This predicted a proportionate enrichment of AMPARs across
all synapses, which is a hallmark of synaptic scaling (Turrigiano,
2008). This led us to believe that GluN2B might be important for
controlling homeostatic synaptic plasticity. Proper circuit forma-
tion requires homeostatic plasticity, which drives cell-wide
changes in synaptic strength in part by regulating AMPAR
contribution. Homeostatic changes in synaptic strength can be
measured as changes in AMPAR-mediated mEPSC amplitudes
(Turrigiano, 2008). Synaptic scaling, evoked in response to
manipulation of activity levels in neuronal cultures, can be tran-
scription dependent or protein translation dependent, and the
effect on individual neurons can vary depending upon cell type
and age in culture (Desai et al., 2002; Wierenga et al., 2005;
Sutton et al., 2006; Turrigiano, 2008). We were able to consis-
tently scale up AMPAR-mediated mEPSC amplitudes in WT
cortical pyramidal neurons between 11 and 15DIV, in response
to chronic activity blockade (24 hr 2 mM TTX) (control = 10.68 ±
0.30 pA, n = 38; TTX = 16.13 ± 0.64 pA, n = 13; p < 0.001) andNeuron 72, 789–805, December 8, 2011 ª2011 Elsevier Inc. 793
Figure 3. Evoked Synaptic Currents in 2B/2A Mouse Cortex
(A) Whole-cell current recordings from layer II/III cortical neurons in response to layer IV stimulation. Example responses are shown (average of at least ten trials)
at holding potentials of 70mV and +50mV to isolate AMPAR-mediated and AMPAR + NMDAR-mediated current, respectively, for both WT and 2B/2A
slices (P16).
(B) In homozygous 2B/2A animals, current at +50mV was strongly suppressed by APV, demonstrating the functional recovery of NMDAR-mediated current.
Cumulative data revealed that peak current amplitudes at +50mV were similar in 2B/2A slices.
(C) This synaptic current in 2B/2A slices was insensitive to the GluN2B specific antagonist ifenprodil, consistent with a switch from GluN2B- to GluN2A-
containing NMDARs.
(D) Replacement of GluN2B with GluN2A in these animals resulted in a predicted and significant decrease in the decay time constant of the current response
at +50mV, resulting in suppression of integrated current when measured over 200 ms. These data show that AMPARs and GluN2A-containing NMDARs are
present at cortical synapses in the absence of GluN2B in the 2B/2A replacement mice.
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with 4 hr of 50 mM APV treatment) (TTX + APV = 14.56 ± 0.86 pA,
n = 13; p < 0.001) (Figures 4B and 4C), consistent with previous
reports (Turrigiano et al., 1998; Sutton et al., 2006; Aoto et al.,
2008).794 Neuron 72, 789–805, December 8, 2011 ª2011 Elsevier Inc.We next examined the role of GluN2B-containing NMDARs in
these regimes of homeostatic plasticity by comparing WT,
GluN2B KO, and 2B/2A replacement neurons. In both GluN2B
knockout neurons and homozygous 2B/2A neurons, scaling
in response to chronic (24 hr) TTX treatment was intact
Figure 4. GluN2B Is Required for Proper Homeostatic Synaptic Scaling in Response to Acute, but Not Chronic, Suppression of Neuronal
Activity
mEPSCs were recorded from cortical cultures prepared from WT, GluN2B KO, and 2B/2A embryos.
(A) When plotted against controls, mEPSCs in GluN2B knockout cultures exhibited a multiplicative increase in mEPSC amplitudes (solid line). The dotted line
shows a predicted additive increase (open circles). This was not rescued byGluN2A expression, as seen by the significantmultiplicative increase inmEPSC event
amplitudes in 2B/2A cultures.
(B) Cultures were tested for their ability to respond to both chronic and acute suppression of neuronal activity. The experimental design is shown schematically
(left) and representative whole-cell voltage-clamp recordings under each condition are presented (right). Traces are 30 s of spontaneous synaptic activity in the
presence of TTX + picrotoxin at a holding potential of 65mV.
(C) Cumulative data reveal the significant increase in mean mEPSC event amplitudes in both GluN2B and 2B/2A knockout cultures compared to age-matched
controls. The ability to scale up mEPSC amplitudes in response to chronic TTX treatment (24 hr TTX) was intact in all three genotypes. However, synaptic scaling
in response to acute TTX and APV treatment (5 hr TTX + 2 hr APV) was occluded in the absence of GluN2B (KO) and was not rescued by genetic replacement with
GluN2A (2B/2A).
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Developmental Role of GluN2B-Containing NMDARs(+36% GluN2B KO, p < 0.001; +19% 2B/2A, p < 0.05) (Fig-
ure 4C). However, activation of NMDARs even in the presence
of TTX can suppress local protein translation, and removing
this suppression results in a rapid multiplicative scaling up
of synapses. This form of scaling is mediated by novel
protein synthesis and can be evoked in response to acute treat-
ment with TTX and APV (5 hr TTX + 4 hr concurrent APV
treatment; see Figures 4B and 4C). In our experiments, acute
treatment with TTX and APV in WT neurons caused a 36%
increase in mEPSC amplitudes, consistent with previous results
(Sutton et al., 2006; Aoto et al., 2008). Additionally, we observed
that this was predominantly due to an initial increase in the
presence of GluA1 (GluR1)-containing AMPARs (Figure S4),
which are replaced over time by GluA2. Interestingly, this form
of homeostatic plasticity was occluded in bothGluN2B knockout
(101% ± 3.8%, p = 0.82) and 2B/2A (100.5% ± 3.2%, p = 0.93)
cultures (Figure 4C).
To confirm these results, we attempted to rescue the increase
in mEPSC amplitudes by cotransfecting GluN2A or GluN2B into
GluN2B null neurons. In these experiments, only GluN2B recov-
eredmEPSC amplitudes toWT control levels, and transfection of
GluN2B into 2B/2A neurons also returned mEPSC amplitudes
to control levels (Figure 5A). Treatment with TTX and ifenprodil
(3 mM) also increased mEPSC amplitudes, supporting a role for
GluN2B-containing receptors in this protein translation-depen-
dent scaling regime (Figure 5B). Interestingly, coapplication of
actinomycin-D (12 mM) blocked scaling in response to 24 hr
TTX (Figure 5C), in line with previous observations suggesting
that synaptic scaling in response to chronic manipulation
requires transcriptional activation (Turrigiano et al., 1998). To
confirm a role for protein translation in the rapid scaling regime,
we also observed that coapplication of the translation inhibitor
anisomycin (40 mM) blocked the increase in mEPSC amplitudes
observed with TTX + APV alone (Figure 5C). Furthermore, the
protein translation blocker cycloheximide (100 mM, 24 hr)
rescued the effect of small interfering RNA (siRNA)-mediated
knockdown of GluN2B in cultures (Figure 5D). Together, these
data strongly suggest that the cellular mechanisms underlying
these two forms of homeostatic synaptic plasticity are disso-
ciable but also that NMDAR-mediated suppression of translation
is likely mediated specifically by GluN2B signaling, and the
downstream cellular signaling pathways responsible for this
regulation are not activated by GluN2A-containing NMDARs.
GluN2B-Containing NMDARs Regulate Phosphorylation
of p70S6K via mTOR
Supporting our conclusion that GluN2B directly, and negatively,
regulates local protein translation in dendrites, both western blot
analysis and immunostaining revealed a strong increase in levels
of phosphorylated p70 ribosomal S6 kinase (p70S6K) in 2B/2A
cultures relative to WT controls (Figures 6A and S5). Levels of
phosphorylated p70S6K correlate positively with the degree of
active protein synthesis in neurons and are positively regulated
by mTOR. To test the potential role of mTOR in acute scaling,
we applied TTX + APV either in the presence or the absence of
the mTOR inhibitor rapamycin (1 mM). The results are consistent
with a role for mTOR signaling in this scaling regime, because
exposure to rapamycin completely blocked the predicted796 Neuron 72, 789–805, December 8, 2011 ª2011 Elsevier Inc.increase in mEPSC amplitudes and levels of phosphorylated
p70S6K (Figures 6B and 6C). To test the potential interaction
between GluN2B signaling and the mTOR pathway, we applied
rapamycin to WT control neurons and neurons expressing
a plasmid-encoded siRNA directed against GluN2B (siRNA-
GluN2B). In both cases, rapamycin significantly reducedmEPSC
amplitudes, suggesting that (1) basal levels of activity are insuf-
ficient to suppress all mTOR signaling, and (2) increased mEPSC
amplitudes in GluN2B null neurons are, at least in part, due to
activation of mTOR signaling (Figure 6D).
To understand the cellular signaling mechanisms responsible
for the specificity of GluN2B function, we performed loss-of-
function mutation rescue experiments in rat cortical cultures. In
cultures from E18 cortices, we transfected neurons at 8DIV
with siRNA-GluN2B and a GFP reporter. Suppression of GluN2B
expression in individual cortical neurons resulted in a significant,
and multiplicative, increase in AMPAR-mediated current at
excitatory synapses, as evidenced by the increase in mEPSC
amplitudes 4 days later (Figures 7A and 7B). The effect of
GluN2B knockdown was specific because it could be rescued
by cotransfection with WT GluN2B (Figure 7C) (Hall et al.,
2007). GluN2A and GluN2B are highly similar proteins (70%
homology in primary protein structure), with the highest degree
of diversity within the COOH tail. Whereas the COOH tails deter-
mine unique intracellular interactions, the extracellular protein
domain, in large part, determines the difference in current
kinetics. We therefore tested whether or not the GluN2B
COOH terminal was required for proper regulation of AMPAR-
mediated currents by cotransfecting a chimeric subunit contain-
ing the GluN2B extracellular N-terminal domain and the GluN2A
intracellular C-terminal domain (2ACterm) (Gallagher et al.,
1996). In these experiments, the chimeric receptor was unable
to rescue the effect of siRNA-GluN2B (siRNA alone = 14.43 ±
0.75 pA, n = 24; siRNA-GluN2B + 2ACterm = 12.95 ± 1.43 pA,
n = 14, p = 0.37), suggesting a critical role for this protein domain.
Interestingly, the reciprocal chimeric receptor, having the
GluN2A N-terminal domain and GluN2B C-terminal domain
(2BCterm), only partially rescued the effect of siRNA-GluN2B
(siRNA-GluN2B + 2BCterm chimera = 12.03 ± 1.04 pA, n = 14).
Taken together, these data suggest that both the current kinetics
and downstream signaling interactions unique to GluN2B are
critical.
GluN2B-Mediated Regulation of AMPAR Current
Requires Interaction with CaMKII
An important kinase that preferentially associates with the
COOH terminus of GluN2B over GluN2A is CaMKII (Strack
et al., 2000; Barria and Malinow, 2005). To test the importance
of this interaction, we cotransfected siRNA-GluN2B along with
a mutant GluN2B receptor that does not interact with CaMKII
(RS/QD: R1300Q; S1303D) (Bayer et al., 2001). When compared
with neurons coexpressing WT GluN2B, the RS/QD mutant
was unable to reverse the siRNA-mediated increase in AMPA-
mEPSC amplitudes (Figure 7C). The similar increase in mEPSC
amplitudes in siRNA-expressing cells and cells expressing
both siRNA and the CaMKII binding mutant suggests that
GluN2B-mediated suppression of synaptic AMPAR incor-
poration requires interaction between GluN2B and CaMKII.
Figure 5. GluN2B Loss of Function Is Not Rescued by GluN2A Expression
(A) mEPSCs were recorded in the presence of TTX (0.5 mM) and picrotoxin (50 mM) in WT, GluN2B, and 2B/2A neuronal cultures between 11 and 15DIV. The
increase in amplitudes observed in the absence of GluN2B was not rescued by transfection with GluN2A, whereas mEPSC amplitudes were recovered by
transfection of GluN2B in GluN2B KO and 2B/2A neurons.
(B) Consistent with a role for GluN2B in rapid scaling up of synaptic strength, 5 hr of treatment with TTX + ifenprodil significantly increased mEPSC amplitudes in
WT mouse cultures.
(C) The transcription inhibitor actinomycin-D (Act-D) blocked synaptic scaling in response to 24 hr TTX treatment, and rapid synaptic scaling in response to 5 hr
TTX + APV treatment was blocked by the translation inhibitor anisomycin (aniso).
(D) Consistent with a role for GluN2B in regulation of local protein translation, 24 hr application of the translation inhibitor cycloheximide depressed mEPSC
amplitudes to control (WT) levels.
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phosphorylation of CaMKII at T286 is significantly reduced in
GluN2B null neuronal dendrites (Figure 7D). Moreover, cotrans-
fection of siRNA-GluN2B along with the CaMKII constitutively
active mutant CaMKII T286D (Fong et al., 1989), but not WT
CaMKII or the nonphosphorylatable mutant T286A, was able to
rescue GluN2B loss of function (Figures 7E and 7F). These
data suggest that both proper localization and activation ofCaMKII downstream of GluN2B are critical for maintaining
appropriate levels of AMPARs at developing cortical synapses.
The decrease in levels of phosphorylated CaMKII was not due
to a decrease in total CaMKII protein, because this was actually
enhanced in the dendrites of siRNA-GluN2B-expressing
neurons (Figure 7D).
Another important protein effector of NMDAR function is
the synaptically localized GTPase activating protein, SynGAP.Neuron 72, 789–805, December 8, 2011 ª2011 Elsevier Inc. 797
Figure 6. Phosphorylated p70S6 Kinase Is Enriched in Dendrites of 2B/2A Neurons and Is Regulated in an mTOR-Dependent Manner
(A) Representative images are shown for WT (top) and homozygous 2B/2A (bottom) neurons in culture after staining for GFP (cell marker) and phosphorylated
p70S6K. Cumulative data showing the statistically significant increase in 2B/2A neurons normalized to WT levels. Scale bar represents 5 mm.
(B) Levels of phosphorylated p70S6K were increased by 5 hr APV + TTX treatment and blocked by treatment with the mTOR inhibitor rapamycin. Increased basal
levels of pP70S6K in 2B/2A neurons could be reduced by treatment with rapamycin.
(C) The increase in mEPSC amplitudes evoked by treatment with 5 hr TTX + APV was also blocked by treatment with rapamycin.
(D) Treatment with an mTOR inhibitor reduced mEPSC amplitudes in WT and siRNA-GluN2B-expressing neurons.
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containing NMDARs, and the phenotype of the SynGAP
knockout animal is strikingly similar to the GluN2B knockout
(Kim et al., 2003; Vazquez et al., 2004; Kim et al., 2005; Kutsu-
wada et al., 1996). We examined SynGAP expression and func-
tion in the 2B/2Amouse, hypothesizing that it could be a major798 Neuron 72, 789–805, December 8, 2011 ª2011 Elsevier Inc.effector of GluN2B signaling at glutamatergic synapses. Consis-
tent with previous reports, we observed a significant decrease in
mean mEPSC amplitudes in neurons transfected with WT full-
length SynGAP (Figures S6A and S6B). From this we inferred
that if SynGAP-mediated regulation of AMPAR trafficking acted
downstream of GluN2B, coexpression of SynGAP would rescue
Figure 7. Regulation of AMPAR-Mediated Currents at Developing Cortical Synapses Requires Interaction between GluN2B and Alpha-
CaMKII
(A) Recordings of AMPAR-mediated mEPSCs at 11–15DIV in cells expressing GFP alone, GFP + 2BsiRNA, or GFP + 2BsiRNA + a non-CaMKII binding GluN2B
mutant subunit (GluN2B-RS/QD).
(B) siRNA-mediated knockdown of GluN2B in cortical rat neurons resulted in a multiplicative increase in mEPSC event amplitudes.
(C) Mean amplitudes are plotted showing the significant increase in mEPSC amplitude in siRNA-expressing neurons, as well as rescue by cotransfection withWT
GluN2B. Cotransfection with GluN2B-RS/QD, a receptor that does not interact with CaMKII, was unable to rescue GluN2B loss of function.
(D) Immunofluorescent images of endogenous phosphorylated CaMKII (anti-pCaMKII) in neurons transfected with GFP alone or with GFP + 2BsiRNA (scale bar
represents 5 mm). Intensity of the dendritic pCaMKII signal was significantly suppressed in 2BsiRNA-expressing neurons, whereas total protein levels were
increased.
(E) mEPSC analysis of neurons transfected with WT CaMKII, constitutively active CaMKII (T286D), or nonphosphorylatable CaMKII (T286A) showing phos-
phorylation at Tyrosine 286 can rescue GluN2B loss of function and restore proper regulation of AMPAR-mediated current at cortical synapses.
(F) mEPSC analysis of neurons transfected with WT CaMKII or the phosphorylation mutant versions of the kinase shows that only constitutively active CaMKII
drives a decrease in mEPSC amplitudes.
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Figure 8. Hyperlocomotion and Reduced Social Exploration in 2B/2A Replacement Mice
Locomotor and social behaviors were tested in homozygous 2B/2A animals and compared with WT, heterozygous 2B/2A (HET), nutrient-deprived (ND), and
cortex-restricted GluN2B knockout mice (2BDCtx).
(A) In a social approach assay, none of the genotypes or conditions showed preference for object exploration when presented with two identical objects.
Homozygous 2B/2A mice failed to match littermate control animals in demonstrating a predicted and statistically significant increased preference for social
exploration when an age-matched juvenile animal was introduced inside one of the objects. 2BDCtx mice also showed significantly altered behavior on this task,
although their performance was statistically significant from 2B/2A animals (* represents compared to WT; # indicates compared to 2B/2A).
(B) In a second sociability test, both 2B/2A and 2BDCtx animals showed significantly higher times in returning to social huddles following physical isolation.
(C) Differences could not be attributed to decreased motor function because both 2B/2A and 2BDCtx animals exhibited increased levels of spontaneous
locomotor activity.
(D) To control for potential changes due to differences in animal size and/or nutritional state, we subjected a subset of WT animals to nutrient deprivation (ND).
Although the size of these animals was brought to 2B/2A levels, they did not show similar change in social behaviors (A–C).
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did not rescue mEPSC amplitudes recorded in GluN2B-siRNA-
expressing neurons (Figure S6B). Furthermore, we tested the
requirement for SynGAP activation in this system by cotransfect-
ing neurons with 2BsiRNA + CaMKII T286D and siRNA against
SynGAP. SynGAP siRNA did not block the rescue induced
by CaMKII T286D, and in neurons expressing 2BsiRNA and
SynGAP siRNA, we observed an additive increase in mEPSC
amplitudes (Figure S6D). Together, these data suggest that
although SynGAP can regulate AMPAR content at developing
synapses, it is not a strong candidate for effecting GluN2B
signaling and regulating homeostatic synaptic plasticity.
Developmentally Expressed GluN2B-Containing
NMDARs Are Required for Normal Social Behaviors
NMDARs are critical for proper circuit development, and
suppression of NMDAR function during development can be
genetically induced via decreased expression of the obligatory
GluN1 subunit (GluN1 hypomorph) (Mohn et al., 1999). This800 Neuron 72, 789–805, December 8, 2011 ª2011 Elsevier Inc.manipulation results in a behavioral phenotype marked by
hyperlocomotion and decreased sociability. Due to the strong
synaptic phenotype we observed in the 2B/2A mice, we
wondered whether the changes observed in the GluN1 hypo-
morph animal might be attributable to specific loss of GluN2B
function during development. In support of this hypothesis,
2B/2A animals exhibited increased spontaneous locomotion
in a familiar cage setting when measured P15–P21 (cage tran-
sect counts per 3 min) (Figure 8C). Observation of homozygous
2B/2A animals also revealed that these animals interact
less frequently with their littermates than control animals. To
determine whether this reflected a deficit in exploratory social
behavior, we used a social approach assay after weaning
(P15–P26) (Silverman et al., 2010). None of the genotypes (WT/
HET/2B/2A) showed preference during the object exploration
phase, as shown by the averageDt values around 0 s (Figure 8A).
However, in the test phase, WT and HET animals then spent
significantly more time exploring the bottle containing themouse
(Figure 8A). In contrast, 2B/2A mice showed a striking
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on the second phase of this task (Figure 8A). Additional observa-
tion of homozygous 2B/2Amice revealed an apparent increase
in time spent isolated from their cage mates. Preweanling WT
and HET animals exhibited a characteristic social behavior
when housed together, in which littermate animals rested in
a huddle. We measured the time required for individual mice to
return unimpeded to a social huddle following removal to the
opposite corner of their home cage. We observed a significant
increase in the amount of time it took for 2B/2A mice to return
following physical isolation (Figure 8B). In fact, a subset of the
2B/2A animals tested did not return within the time allotted
for the test (150 s). The 2B/2A animals’ ability to see and smell
was evident by their reaction to attempted physical contact and
their ability to locate food and water. We also tested the potential
confound of decreased nutrition in these animals by restricting
wild-type animals from food in order to stunt their growth to
a similar degree. Interestingly, although nutrient deprivation
(ND) was successful in reducing body mass in WT mice to levels
similar to 2B/2A mice, it did not mimic changes observed in
social behavioral tests (Figure 8), in spite of the fact that this
manipulation has previously been shown to suppress social
exploratory behaviors (Almeida and De Arau´jo, 2001). In that
previous report, however,malnutritionwas continued for a longer
period.
Another important question is, are these behavioral changes
the result of GluN2B loss of function or of premature expression
of GluN2A? To clarify this, we performed behavioral analysis
using a GluN2B conditional knockout mouse (Brigman et al.,
2010). This allowed us to compare the social phenotype of
animals lacking GluN2B (2BDCtx) to 2B/2A animals express-
ing GluN2A in the absence of GluN2B. We used the NexCre
mouse to rescue GluN2B function in subcortical regions and
restrict gene excision to primary neurons of the neocortex
and hippocampus (Goebbels et al., 2006). Interestingly, we
observed very similar phenotypes in the 2BDCtx mice in terms
of hyperlocomotion and altered social behavior (Figure 8).
Although these data suggest that the social phenotype might
be due primarily to cortical loss of GluN2B, and not to prema-
ture expression of GluN2A, they also revealed that 2B/2A
mice perform significantly worse on the social exploration
task than 2BDCtx animals (Figure 8A). From this we conclude
that these social deficits are not due simply to malnourishment
and that the majority of the behavioral phenotype can be
attributed to loss of GluN2B, although it is possible that
premature expression of GluN2A enhances the deficit in social
exploration.
DISCUSSION
The primary observation from these studies is that GluN2B-
mediated signaling during development cannot be rescued by
premature expression of the mature NMDAR subunit GluN2A.
This provides strong evidence that these subunits serve distinct
functional roles. In terms of synaptic function, we show that
GluN2B-containing NMDARs are necessary for appropriate
regulation of AMPAR-mediated currents and play a critical role
in protein translation-dependent homeostatic plasticity. Addi-tionally, our data suggest that their unique interaction with
CaMKII is responsible for the distinct cellular signaling associ-
ated with GluN2B-containing NMDARs and that suppression of
protein translation by these receptors involves the mTOR
pathway. Interestingly, a recent report has shown that rapid anti-
depressant effects of NMDAR antagonists involve activation of
the mTOR pathway and rapid stabilization of cortical synapses
(Li et al., 2010). The data presented here provide evidence that
this may be due to disruption of GluN2B signaling, which acts
via mTOR to suppress local protein synthesis in cortical
dendrites.
A Critical Role for GluN2B-Containing NMDARs during
Cortical Development
GluN2B knockout mice die at P0, and this has largely precluded
studies of the role of this subunit during development (Kutsu-
wada et al., 1996), whereas the absence of any dramatic survival
phenotype in GluN2A null mice is consistent with their weak
expression during embryogenesis and early postnatal periods
(Sakimura et al., 1995). Recent reports have presented data
from conditional GluN2B knockout mice; however, these
studies have largely focused on the consequences of genetic
removal after initial circuit formation (Brigman et al., 2010; von
Engelhardt et al., 2008; Akashi et al., 2009). In light of this
and of evidence that GluN2B may be uniquely required for
proper localization of plasticity-related signaling molecules at
excitatory synapses (Foster et al., 2010), we focused on exam-
ining the specific role of GluN2B during early postnatal
development.
During this period, homeostatic synaptic plasticity is required
to maintain neuronal excitability within a physiologically appro-
priate range, because both the number of synapses onto indi-
vidual neurons and sensory-driven activity increases in cortical
networks. Homeostatic synaptic plasticity controls synapse
excitability in a bidirectional manner, in part by regulating incor-
poration of synaptic AMPARs (Turrigiano, 2008). Scaling up
synaptic AMPAR contribution in response to chronic suppres-
sion of neuronal activity has been shown to be dependent
upon transcription but independent of NMDAR function (Turri-
giano, 2008). In support of this, we found that scaling in response
to chronic TTX treatment was intact in both GluN2B null and
2B/2A neurons. Relatively rapid homeostatic scaling up of
synapses can also be evoked acutely by blocking NMDAR-
mediated suppression of local protein translation. This increase
in AMPAR-mediated current results from activation of local
protein synthesis and increased availability of AMPAR sub-
units (Ju et al., 2004; Sutton et al., 2004, 2006). We found that
protein translation-dependent scaling is occluded in the
absence of GluN2B and is not rescued in 2B/2A neurons,
suggesting that NMDAR-mediated suppression of protein trans-
lation is subunit specific. From this we infer that a dominant
role for GluN2B-containing NMDARs during development is
to maintain appropriate levels of protein translation in dendrites
in order to regulate synapse excitability. Consistent with this,
we observed increased levels of phosphorylated S6K in
dendrites lacking GluN2B and increased surface expression of
AMPAR subunits GluA1 and GluA2 in dendrites of GluN2B null
neurons (Hall et al., 2007). mRNAs encode GluA1 and GluA2Neuron 72, 789–805, December 8, 2011 ª2011 Elsevier Inc. 801
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Interestingly, antagonism of GluN2B-containing NMDARs
results in upregulation of synaptic protein translation in vivo
through activation of the mTOR pathway (Li et al., 2010). This
suggests that it is through regulation of local protein synthesis
that GluN2B antagonistsmay exert their effects as strong antide-
pressants (Maeng et al., 2008; Preskorn et al., 2008; Li et al.,
2010). It will be critically important to determine the exact molec-
ular mechanism by which NMDARs, and specifically GluN2B,
regulate protein synthesis in neuronal dendrites and to identify
the RNA messages involved.
GluN2B-Containing NMDAR Function Is Mediated
by CaMKII
Our experiments suggest that the specificity of GluN2B function
is mediated through its preferential association with CaMKII.
Regulation of AMPAR-mediated currents at developing cortical
synapses requires CaMKII function downstream of GluN2B,
because expression of a subunit mutant unable to interact with
CaMKII is ineffective at rescuing GluN2B loss of function. Impor-
tantly, although we observed that levels of activated (phosphor-
ylated) CaMKII are depressed in the absence of GluN2B
signaling, we actually observed an increase in the protein
expression levels of this kinase and a decrease in the levels of
beta CaMKII (data not shown). Interestingly, bidirectional
homeostatic synaptic plasticity has been shown to involve recip-
rocal regulation of alpha and beta CaMKII (Thiagarajan et al.,
2002; Groth et al., 2011). Thus, it will be important in future
studies to determine the exact conditions and mechanisms by
which these enzymes are regulated by GluN2B and GluN2A-
mediated signaling. Because of its role in NMDAR-mediated
long-term potentiation (LTP), the observation that CaMKII may
also play a critical role in suppressing AMPAR insertion at devel-
oping synapses may at first seem contradictory; however, this
can be rectified by the following two, nonmutually exclusive,
predictions: (1) basal activation of GluN2B-containing NMDARs
suppresses AMPAR contribution through weak activation of
CaMKII, whereas strong activation leads to a dissociation of
this mechanism and increased AMPAR contribution, and/or (2)
LTP at young cortical synapses relies on protein kinase A,
whereas CaMKII plays a larger role at mature synapses (Yasuda
et al., 2003). Furthermore, due to its early dominance, GluN2B
probably plays a more significant role during synapse formation
in the cortex, and signaling via this subunit may actually
decrease in prominence due to increased expression of GluN2A
subunits and the formation of triheteromeric receptors or
through the movement of GluN2B-containing NMDARs to peri-
synaptic regions. Reports suggest that the majority of NMDARs
in the mature hippocampus are in fact triheteromeric (Rauner
and Kohr, 2011). It is thus plausible that one consequence of
the increase in GluN2A expression is suppression of the avail-
ability of GluN2B-containing receptors. The idea that these
aspects of GluN2B function dominate developing synapses
and decrease with age is supported by recent reports in which
GluN2B was removed after initial cortical circuit development
using a conditional GluN2B knockout animal. In these experi-
ments, no change in AMPAR-mediated mEPSC amplitudes
was observed (von Engelhardt et al., 2008).802 Neuron 72, 789–805, December 8, 2011 ª2011 Elsevier Inc.GluN2B-Containing NMDARs and SynGAP
In addition to a potential role for CaMKII in defining GluN2B func-
tion, vis a vis GluN2A, we also tested the role of the synaptic G
protein activating enzyme SynGAP, which associates preferen-
tially with GluN2B over GluN2A (Kim et al., 2005). The phenotype
of the SynGAP knockout animal is strikingly similar to that of the
GluN2B null: homozygous knockout animals die at early post-
natal ages but exhibit increased AMPAR contribution at cortical
synapses (Kutsuwada et al., 1996; Kim et al., 2003; Vazquez
et al., 2004; Rumbaugh et al., 2006). Additionally, heterozygous
SynGAP animals show a behavioral phenotype consistent with
schizophrenia-like symptoms in mice, including a preference
for social isolation and hyperlocomotion (Guo et al., 2009). These
data are supportive of the conclusion that SynGAP may be
a major effector of GluN2B function; however, although our
data confirmed that overexpression of SynGAP at cortical
synapses drives down AMPAR-mediated currents, SynGAP
overexpression was unable to rescue GluN2B loss of function
as predicted. Because CaMKII is a strong activator of SynGAP
(Oh et al., 2004), we inferred that this might be due to decreased
CaMKII function. However, suppression of SynGAP activity via
siRNA knockdown did not block the rescue of GluN2B loss of
function by constitutively active CaMKII (T286D), suggesting
that these enzymes may act via parallel pathways or may func-
tion at independent synapses. This remains to be fully resolved,
yet, it is important to note that GAP proteins are known to regu-
late translation in neurons: the GAP domain-containing protein
TSC2, which associates with TSC1, directly regulates mTOR
function (Hoeffer and Klann, 2010).
GluN2B Loss of Function and Schizophrenia-like
Behaviors in Mice
NMDARs have been implicated in numerous cellular processes
and psychiatric disorders. Studying behavioral effects of
NMDAR antagonism in humans has led to the hypothesis that
glutamatergic synapse dysfunction may be the root cause of
schizophrenia (Belsham, 2001; Moghaddam, 2003). In addition,
suppression of NMDAR function during development recapitu-
lates schizophrenia-like symptoms in adult mice (Stefani and
Moghaddam, 2005). Supporting a hypoglutamate hypothesis
of schizophrenia, mice with suppressed NMDAR function have
been generated as effective animal models of this disorder
(Mohn et al., 1999; Belforte et al., 2010). One of these, the
GluN1 hypomorph mouse, exhibits a phenotype that includes
hyperlocomotion and altered sociability. Because of the lethality
associated with the GluN2B global knockout mouse, the role of
GluN2B in the expression of this behavioral phenotype had not
been tested. GluN1 hypomorph animals exhibit a reduction in
total NMDAR expression to approximately 5%–10%. In contrast,
in 2B/2A homozygous animals, approximately 60% of the inte-
grated cortical NMDAR current is recovered, but it is now medi-
ated purely by GluN2A-contaning NMDARs. Interestingly, this
manipulation recapitulates a behavioral phenotype of hyperloco-
motion and altered sociability. This predicts that aspects of the
behavioral phenotype associated with suppressed NMDAR
dysfunction in the GluN1 hypomorph may be specifically due
to a loss of GluN2B-containing NMDAR signaling during devel-
opment. We also show that developmental excision of GluN2B
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lates aspects of the phenotype observed in the 2B/2A animal.
It has previously been shown that suppression of NMDAR func-
tion in cortical and hippocampal GABAergic interneurons results
in schizophrenia-like symptoms in mice (Belforte et al., 2010).
Although future experiments are needed to compare and
contrast the phenotypes of these animals, data suggest that
changes in corticolimbic excitatory and inhibitory balance may
underlie these behavioral alterations.
In summary, our experiments show that GluN2B is a critical
regulator of homeostatic synaptic plasticity and social behavior.
They demonstrate that GluN2A, in spite of being functionally
expressed in the absence of GluN2B at cortical synapses, is
unable to rescue GluN2B loss of function. We infer that a major
function of GluN2B-containing NMDARs is to suppress local
protein translation in dendrites through interaction with down-
stream signaling molecules, including alpha-CaMKII and the
mTOR pathway.
EXPERIMENTAL PROCEDURES
Animal Care and Use
Animal protocols were approved by the Tulane Institutional Animal Care and
Use Committee as mandated by the National Institutes of Health’s Office of
Laboratory Animal Welfare and the United States Department of Agriculture
and were accredited by the Association for the Assessment and Accreditation
of Laboratory Animal Care.
Cell Culture
Cell cultures were prepared as previously described (Hall et al., 2007).
GluN2B KO Mice
GluN2B null, heterozygous, and wild-type mouse cultures were generated
from E16–E17 mouse embryos derived from heterozygous GluN2B matings
(Kutsuwada et al., 1996).
Genetic Replacement of GluN2B by GluN2A
To generate the 2B/2A targeting construct, we isolated a portion of the sixth
chromosome from a phage-based library of wild-type-129 mouse DNA, prob-
ing for the initial coding exon of the GluN2B gene (429 bp-exon 4). The cloned
fragment (pD1) was z14 kbp in length and contained the entire exon. From
pD1, a 7.3 kbp fragment, including 4.3 kbp of 30 flanking sequence, was
excised. This was cloned into a pBluscript vector to generate pBluD1_N/B.
The 2B/2A targeting construct contained (from 50 to 30 ) an intronic flanking
region, the first z70 bp of exon 4, full-length cDNA for rat GluN2A, and
a loxP flanked neo selection cassette. The introduced GluN2A cDNA removed
most of exon 4, including the initial ATG, resulting in nonsense transcript
downstream of the GluN2A coding sequence. The construct was confirmed
by restriction digest and PCR analysis, then purified and introduced into
WT-129 (male) mouse embryonic stem cells (ESCs). ESCs were selected for
neomycin resistance, and homologous recombination was confirmed using
an upstream genomic probe that identified incorporation of the targeting
construct by predicted size shift in Southern blots. Positive clones were karyo-
typed and injected into pseudopregnant C57/B6mice. Male chimeric offspring
were bred with pure C57/B6 mice to assess germline transmission. Propaga-
tion of the targeted alleles was confirmed and followed by PCR analysis.
Primers for genotyping were the following: WT forward TTCTCCCAAGTT
CTGGTTG, WT reverse GATGCGGGTGATTATGCT, 2B/2A forward CCTCC
TGGTGTTTCCAGTGT, and 2B/2A reverse GCGACTCTCAGACCTCATCC.
GluN2B Conditional KO Mice
Cortical GluN2B KO was accomplished by crossing animals containing a loxP
flanked exon 5 (Brigman et al., 2010) with mice expressing Cre-recombinase
under the cortex specific Nex locus (Goebbels et al., 2006). GluN2B flox/+ ;Nex-Cre/+ mice were crossed with GluN2B flox/+ or GluN2B flox/flox mice
to obtain GluN2B flox/flox ; Nex-Cre/+ mice, which are referred to as 2BDCtx
mice. Mice that were GluN2B flox/+ and GluN2B flox/flox but WT at the Nex
locus served as controls.
Electrophysiology
Synaptic activity was recorded from cell cultures and acute brain slices while
perfused at room temperature in a bicarbonate buffered solution containing
124 mM NaCl, 5 mM KCl, 26 mM NaHCO3, 1.23 mM NaH2PO4, 1.5 mM
MgCl2, 2 mM CaCl2, and 10 mM glucose and bubbled constantly with 95%
O2/5% CO2. Voltage-clamp recordings were made using glass microelec-
trodes (borosilicate glass 1.5 mm outer diameter and 0.86 mm inner diameter,
Warner Instruments, Hamden, CT), pulled on a micropipette puller (Flaming-
Brown P-80/PC, Sutter Instrument , Novato, CA), and filled with a cesium-
substituted intracellular solution containing 10 mM CsCl, 105 mM CsMeSO3,
8 mM NaCl, 0.5 mM ATP, 0.3 mM GTP, 10 mM HEPES, 5 mM glucose,
2 mM MgCl2, and 1 mM EGTA (pH 7.3). Pipette resistances ranged
3–13 MU. Series access resistance ranged fromz7 to 35 MU and was moni-
tored for consistency. Signals were recorded using a patch-clamp amplifier
(PC505B, Warner Instruments) and digitized with a BNC-2111 A/D board
(National Instruments, Austin, TX) using custom-written software in Igor
Pro (WaveMetrics, Lake Oswego, OR). Signals were amplified, sampled at
10 kHz, filtered to 2 or 5 kHz, and analyzed using custom routines in Igor
Pro. TTX, APV, and picrotoxin were all from Tocris Bioscience (Ellisville,
MO). GluN2B-siRNA used in these studies was previously described (Hall
et al., 2007). All recordings were performed on pyramidal neurons. In slice
recordings, layer II pyramidal neurons were targeted for recording, and slices
of cortex were within two sections (700 mm) of the primary somatosensory
cortex, as evident by the presence of barrel structures, observable in live
differential interference contrast images. Synaptic responses were evoked
using concentric bipolar stimulating electrodes placed in layer IV (Frederick
Haer, Bowdoin, ME). Current was evokedwith a stimulus isolation unit (Cygnus
Technology, Delaware Water Gap, PA) controlled by a PG4000A digital stimu-
lator (Cygnus Technology). For local NMDA stimulation (Figures 2 and S2D),
glass electrodes of similar resistance (z5 MU) were filled with agonist
(NMDA andD-serine) in artificial cerebral spinal fluid, to whichwe applied short
(10–60 ms), repetitive (10 s intervals) pressure stimulation (18 psi), using
a Picospritzer II (General Valve, Fairfield, NJ).
Immunohistochemistry
All of the following antibodies were used at 1:1,000 dilution: anti-CaMKII
(Abcam), anti-phosphoCaMKII (Abcam), anti-GluN2A (Millipore), and anti-
GluN2B (University of California, Davis/National Institutes of Health NeuroMab
Facility clone number 59/20). Surface staining was performed as previously
described (Hall et al., 2007).
Behavioral Assays
All behavioral testing was conducted at the beginning of the animals’ 12 hr
dark cycle under low ambient light. Detailed methods for these tests are pre-
sented in the Supplemental Experimental Procedures.
Statistical Analysis
Statistical significance was confirmed by t test comparison of mean values
obtained from each genotype (or experimental condition) compared to control.
All data (text and figures) are presented as mean ± SEM. *p < 0.05, **p < 0.01,
and ***p < 0.001.
SUPPLEMENTAL INFORMATION
Supplemental Information includes six figures and Supplemental Experimental
Procedures and can be found with this article online at doi:10.1016/j.neuron.
2011.09.023.
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